Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial

Benutzer: Gast

Titel:: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Levin, Johannes; Sing, Nand; Melbourne, Sue; Morgan, Amber; Mariner, Carla; Spillantini, Maria Grazia; Wegrzynowicz, Michal; Dalley, Jeffrey W.; Langer, Simon; Ryazanov, Sergey; Leonov, Andrei; Griesinger, Christian; Schmidt, Felix; Weckbecker, Daniel; Prager, Kai; Matthias, Torsten; Giese, Armin
Zeitschriftentitel:: eBioMedicine
Jahr:: 2022
Band / Volume:: 80
Seitenangaben Beitrag:: 104021
Volltext / DOI:: doi:10.1016/j.ebiom.2022.104021
Verlag / Institution:: Elsevier BV
E-ISSN:: 2352-3964
Publikationsdatum:: 01.06.2022
BibTeX

Vorkommen: